Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download Current HansardDownload Current Hansard    View Or Save XMLView/Save XML

Previous Fragment    Next Fragment
Thursday, 12 August 2004
Page: 26381

Senator ALLISON (5:26 PM) —On that point, is it the case that, because the PBAC must make public all of its reasons for deciding not to list a drug on the PBS, there is a problem insofar as the agreement acknowledges the rights of innovative drug manufacturers but not the rights of government to negotiate the lowest price? It seems to me that a lot of the criticisms of what you have negotiated are that the principle is there which establishes and recognises the rights of innovative pharmaceutical companies but not the other right—which is part of the PBAC's deliberations and is one of public good—to negotiate a product at the lowest price. Is it not the case that by making those reasons transparent you open up to challenge any decisions in which the rights of the drug manufacturers are not paramount?